Comparative Effects of High-Intensity Interval Training and Continuous Endurance Training Among P… (NCT07713030) | Clinical Trial Compass
RecruitingNot Applicable
Comparative Effects of High-Intensity Interval Training and Continuous Endurance Training Among Prediabetic Patients
Pakistan80 participantsStarted 2026-05-01
Plain-language summary
Prediabetics is a condition where blood sugar levels are normal but not yet high enough to be diagnosed as type 2 diabetes. This phase offers a crucial point for timely intervention to delay or prevent type 2 diabetes. The objective of the study will be to find the effects of high intensity interval and continuous endurance training on glycemic control, BMI, Vo2 Max, pulmonary function and physical activity among prediabetic patients. Study design will be randomized control trial. Total 80 participants will be enrolled in study. The data will be collected from faculty of Riphah International University, Lahore. The study will be completed within 8 months after approval of synopsis. A simple random sampling will be used to assign the groups; group A and group B. Group A will be assigned high intensity interval training and group B will be assigned to continuous training.
Who can participate
Age range
35 Years – 54 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Sedentary lifestyle (Individuals reporting minimal structured physical activity e.g., \<30 minutes of exercise per week) .
* Stable Medical Condition (No history of significant cardiovascular events, uncontrolled hypertension, or other major comorbidities).
* Stable Body Weight (Stable body weight with changes less than 3 kg in the past 6 months).
Exclusion Criteria:
* uncontrolled hypertension
* history of heart disease
* myocardial infarction
* stroke
* Use of Specific Medications (Current use of insulin or other medications affecting glucose metabolism or exercise response)
* Severe Obesity (Individuals with a BMI ≥ 40 kg/m)
* High fasting blood glucose (Fasting blood glucose of \>100mg.dl-1)
* Previous history of respiratory problems
* Smoking
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.